Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain

Costs related to the management of acute HAE attacks with C1 inhibitor deficiency may be substantially reduced through interventions targeting home treatment by training patients to self-administer icatibant.